Persons who require blood transfusion at the time of surgery, although the name of the disease is not specified.
Conditions
Interventions
Before transfusion, 1-3 weeks and 3-5 weeks after transfusion (but at least 2 weeks after the second blood draw) 3 mL of venous blood is drawn from the subject.
Sponsors
Anti-Dpoing Laboratory, LSI Medience Corporation
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Subjects who meet all of the following selection criteria are selected. 1. A person who has received or are scheduled to receive a transfusion for treatment within the past 3 weeks 2. Nationality Japan 3. A person who is judged by the medical institution research director or the medical institution research coordinator to have no problem in participation
Exclusion criteria
Exclusion criteria: Study subjects who violate any of the following exclusion criteria are excluded. 1. A person who suffers from infectious disease or blood disease. 2. Alcohol or drug addicts, people who are depressed. 3. A person who has not recovered from a serious condition. 4. A Person who has received at least 2 blood transfusions in the past 6 months. 5. Subjects whose sampling in this study may adversely affect the patient's condition. 6. A person weighing less than 50 kg for men and less than 40 kg for women. 7. A person who is considered inappropriate to participate in this research by the medical institution research director or the medical institution research coordinator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The sensitivity and specificity of the measurement of transfused red blood cells by flow cytometry are evaluated by measuring the blood of transfused patients. | — |
Secondary
| Measure | Time frame |
|---|---|
| Requirements for application to routine test | — |
Countries
Japan
Contacts
Public ContactMitsuhiko Sato
LSI Medience Corporation
Outcome results
None listed